CR6627A - Nuevo medicamento contraceptivo y su modo de preparacion - Google Patents

Nuevo medicamento contraceptivo y su modo de preparacion

Info

Publication number
CR6627A
CR6627A CR6627A CR6627A CR6627A CR 6627 A CR6627 A CR 6627A CR 6627 A CR6627 A CR 6627A CR 6627 A CR6627 A CR 6627A CR 6627 A CR6627 A CR 6627A
Authority
CR
Costa Rica
Prior art keywords
preparation mode
medicinal product
new
contraceptive
domain
Prior art date
Application number
CR6627A
Other languages
English (en)
Inventor
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9542725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR6627(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of CR6627A publication Critical patent/CR6627A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

La presente invencion concierne el dominio de la quimica, y mas particularmente el dominio de la quimica terapeutica. Tiene particularmente por objeto nuevas composiciones con un proposito contraceptivo formadas de un progestativo y un estrogeno. Tiene especificamente como objeto nuevas composiciones famraceuticas con un proposito contraceptivo caracterizados porque contienen como principios activos un ester de nomegestrol y estradiol en asociacion o mezclado con un excipiente o un vehiculo inerte no toxico, farmaceuticamente aceptable, conveniente para la administracion por via bucal.
CR6627A 1999-10-25 2002-04-24 Nuevo medicamento contraceptivo y su modo de preparacion CR6627A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FR1999/002587 WO2001030355A1 (fr) 1999-10-25 1999-10-25 Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation

Publications (1)

Publication Number Publication Date
CR6627A true CR6627A (es) 2008-06-18

Family

ID=9542725

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6627A CR6627A (es) 1999-10-25 2002-04-24 Nuevo medicamento contraceptivo y su modo de preparacion

Country Status (21)

Country Link
EP (2) EP2020236B1 (es)
JP (1) JP5484646B2 (es)
KR (1) KR100549625B1 (es)
CN (1) CN1205936C (es)
AP (1) AP1707A (es)
AU (1) AU784478B2 (es)
BR (1) BR0014952A (es)
CA (1) CA2388857C (es)
CR (1) CR6627A (es)
CZ (1) CZ301982B6 (es)
ES (1) ES2565688T3 (es)
HK (1) HK1048600A1 (es)
HU (1) HU230467B1 (es)
IL (2) IL149141A0 (es)
MX (1) MXPA02004083A (es)
NO (1) NO330885B1 (es)
NZ (1) NZ518308A (es)
OA (1) OA12071A (es)
RU (1) RU2258512C2 (es)
WO (2) WO2001030355A1 (es)
ZA (1) ZA200203399B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
KR100975350B1 (ko) * 2002-11-29 2010-08-12 재단법인서울대학교산학협력재단 사람 락토페리신을 생산하는 형질전환 복제 소 및 이것의생산방법
CN104208067A (zh) * 2004-07-07 2014-12-17 惠氏公司 周期性黄体酮方案及试剂盒
ES2381495T3 (es) * 2005-05-26 2012-05-28 Teva Women's Health, Inc. Formas de dosificación oral que comprenden progesterona y métodos para fabricar y usar las mismas
CN103877059A (zh) * 2014-03-26 2014-06-25 邵娜 一种醋酸诺美孕酮片及其制备工艺

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
EP0559240B1 (en) 1987-09-24 2001-12-05 Jencap Research Limited Contraceptive packages containing oestrogen and progestin
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5532416A (en) 1994-07-20 1996-07-02 Monsanto Company Benzoyl derivatives and synthesis thereof
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19529767A1 (de) 1995-08-12 1997-02-13 Huels Chemische Werke Ag Amphiphile Verbindungen mit mehreren hydrophilen und hydrophoben Gruppen auf der Basis von Aminobernsteinsäurederivaten
US5902914A (en) 1995-08-14 1999-05-11 Alliedsignal Inc. Process for the preparation of halogenated alkanes
AUPN479995A0 (en) 1995-08-15 1995-09-07 Leon Kruss Technology Pty Limited Lightweight cementitious composition
US5654494A (en) 1995-08-18 1997-08-05 Alliedsignal Inc. Process for the manufacture of 1,1,1,2-tetrafluoroethane
US5530167A (en) 1995-08-21 1996-06-25 Eastman Chemical Company Process for the preparation of 1,4-butenediol
JP3616966B2 (ja) 1995-10-02 2005-02-02 エヌエスケー・オートリブ株式会社 シートベルト用リトラクター
DE19536745A1 (de) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wischblatt für eine Scheibenwischervorrichtung eines Fahrzeuges, insbesondere eines Kraftfahrzeuges
DE19536742A1 (de) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wischblatt für eine Scheibenwischvorrichtung eines Fahrzeuges
DE19536744A1 (de) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wischblatt mit auswechselbarem Wischgummi für einen Fahrzeugscheibenwischer
DE29515703U1 (de) 1995-10-02 1996-02-08 Föhl, Artur, 73614 Schorndorf Drehantriebsvorrichtung für einen Gurtstraffer
EP0770338B1 (en) 1995-10-23 2002-09-25 Honda Access Corp. Cap body of a helmet
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de) 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
WO1997041868A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
GB9621990D0 (en) 1996-10-22 1996-12-18 Scotia Pharma Ltd Use
DE19705229C2 (de) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
AU9028098A (en) 1997-08-27 1999-03-16 Ortho Pharmaceutical Corporation Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
JP2001516720A (ja) 1997-09-12 2001-10-02 アメリカン・ホーム・プロダクツ・コーポレイション プロゲスチン／エストロゲンからなる第一相とプロゲスチンからなる第二相とを有する経口避妊薬製剤

Also Published As

Publication number Publication date
HUP0203443A2 (hu) 2003-01-28
JP5484646B2 (ja) 2014-05-07
AU784478B2 (en) 2006-04-13
HK1129564A1 (zh) 2009-12-04
OA12071A (fr) 2006-05-04
IL149141A0 (en) 2002-11-10
AU1033501A (en) 2001-05-08
JP2003518013A (ja) 2003-06-03
CN1205936C (zh) 2005-06-15
NO20021948L (no) 2002-06-25
NZ518308A (en) 2006-01-27
HUP0203443A3 (en) 2003-12-29
RU2002113654A (ru) 2004-01-27
AP2002002485A0 (en) 2002-06-30
ES2565688T3 (es) 2016-04-06
MXPA02004083A (es) 2003-08-20
RU2258512C2 (ru) 2005-08-20
NO20021948D0 (no) 2002-04-25
CZ301982B6 (cs) 2010-08-25
CN1382054A (zh) 2002-11-27
PL354518A1 (en) 2004-01-26
EP1227815A1 (fr) 2002-08-07
HK1048600A1 (zh) 2003-04-11
EP2020236B1 (fr) 2016-01-27
WO2001030355A1 (fr) 2001-05-03
BR0014952A (pt) 2003-07-29
AP1707A (en) 2007-02-26
ZA200203399B (en) 2004-02-09
EP2020236A1 (fr) 2009-02-04
WO2001030358A1 (fr) 2001-05-03
KR100549625B1 (ko) 2006-02-08
IL149141A (en) 2008-06-05
KR20020073333A (ko) 2002-09-23
NO330885B1 (no) 2011-08-08
HU230467B1 (hu) 2016-07-28
CA2388857C (fr) 2011-06-07
CA2388857A1 (fr) 2001-05-03
CZ20021426A3 (cs) 2002-08-14

Similar Documents

Publication Publication Date Title
MA26834A1 (fr) Nouveau medicament contraceptif et son mode de preparation
EP2246049A3 (en) Pharmaceutical composition and dosage forms for administration of hydrophobic drugs
BRPI0400214A8 (pt) Composições e aplicações farmacêuticas para a obtenção confiável de níveis aceitáveis de testosterona no soro
ES2281551T3 (es) Metodo de prevencion o tratamiento de enfermedades ginecologicas benignas.
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
YU54602A (sh) Drospirenon za terapiju zamene hormona
TW200514560A (en) Pharmaceutical formulation for contraception and hormone-replacement therapy
AR033042A1 (es) Terapia de reemplazo hormonal
SI1526856T1 (sl) Farmacevtski sestavek, ki obsega estetrolne derivate za uporabo pri zdravljenju raka
CR10289A (es) "estratrienos 9-alfa-sustituidos como estrogenos de eficacia selectiva"(divisional)
CR6627A (es) Nuevo medicamento contraceptivo y su modo de preparacion
MY128482A (en) New hormonal composition and its use
AP1625A (en) Hormonal composition based on a progesterone and an oestrogen and use thereof.
EP1857111A3 (en) Composition comprising a combination of an aromatase inhibitor, a progestin and an estrogen, and its use for the treatment of endometriosis
WO2001021194A3 (en) Method for the therapeutic management of endometriosis and fallopian tube obstruction
EE200300310A (et) Ravimkompositsioon, mis sisaldab östrogeeni ja muid hormoone kombinatsioonis askorbaadi, lüsiini, proliini ja teiste toimeainetega, ning selle kasutamine
BR0013711A (pt) Mesoprogestinas (moduladores de receptores de progesterona) como um componente de contraceptivos femininos
JP2005532336A5 (es)
PT768896E (pt) Comprimidos de esteroides de baixa dosagem que contem como antioxidante esteres de acido galico processo para a sua preparacao e sua utilizacao
AR033260A1 (es) Nueva composicion hormonal y su utilizacion
MXPA05003364A (es) Parche transdermico de 17(-estradiol/levonorgestrel para hormonoterapia restitutiva.
RU1789216C (ru) Состав, обладающий контрацептивным действием
HRP20070360B1 (hr) Drospirenon za hormonsku nadomjesnu terapiju
EP1857110A3 (en) Hormone replacement therapy

Legal Events

Date Code Title Description
FC Refusal